Navigation Links
Inovio Pharmaceuticals' Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress
Date:10/5/2011

BLUE BELL, Pa., Oct. 5, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of synthetic vaccines against cancers and infectious diseases, announced today that the company's research to develop a therapeutic synthetic vaccine for cancer won the Edward Jenner Poster Award First Prize at the recent 5th Vaccine and ISV Global Congress. This prestigious prize recognizes the most promising research at the Congress. Inovio's poster, entitled "Induction of HPV specific CTLs in human volunteers after DNA immunization," was selected from over 500 abstracts by the scientific organizing committee and an expert panel of judges. The award citation highlighted Inovio's pioneering therapeutic cervical dysplasia/cancer vaccine program and the novel assay for determining vaccine impact.

The Vaccine Congress is a forum for a state-of-the-art report on the latest progress in the development of vaccines for infectious and non-infectious diseases. The annual Jenner Award is named after Edward Jenner (1749-1823), who is widely credited as the pioneer of the smallpox vaccine and is often referred to as the "Father of Immunology."

Inovio presented data showing the development of a novel flow cytometry-based assay to assess cytolytic T cell (CTL) activity in immunized patients. Blood samples collected from subjects immunized with Inovio's SynCon® therapeutic HPV 16 and 18 vaccine (VGX-3100) were analyzed by the new assay. Inovio previously announced the results of its Phase I clinical trial demonstrating the induction of strong T-cell immune responses to the vaccine. An important aspect of a therapeutic vaccine is its ability to generate antigen-specific cytolytic CD8+ T cells that can kill infected host cells. Using the new assay, Inovio scientists were able to demonstrate for the first time that the vaccines developed fully functional CTLs ca
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
2. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
3. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
4. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
5. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
6. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
7. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
8. Inovio Pharmaceuticals Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovios Electroporation Delivery Technology
9. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
10. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
11. Inovio Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... N.J. , May 23, 2013 Nephros, ... commercial stage medical device company that develops and sells ... completion of its rights offering.  In addition, the concurrent ... 2011 warrants expired on May 17, 2013. ... $3.0 million from the rights offering.   A portion of ...
(Date:5/23/2013)... KNOXVILLE, Tenn. , May 23, 2013 /PRNewswire/ ... of 24-hour nurse triage and nurse advice lines, ... 10-person committee, comprising physician, nursing and administrative leaders, ... providing safe, quality and cost-effective services for hospital ... "As our national healthcare system evolves, it,s imperative ...
(Date:5/23/2013)... 2013 Anthem Blue Cross patients with HIV/AIDS ... them to obtain their medications by mail order under ... Kallas LLC.  The lawsuit, filed in ... Cross,s mandatory mail order program announced late last year ... "This settlement brings to a close a ...
Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3
... 7, 2012  BioSpecifics Technologies Corp. (NASDAQ: BSTC ), ... as XIAFLEX ® in the U.S. and XIAPEX ® ... and time for its conference call and live audio webcast ... a corporate update. The conference call is now scheduled for ...
... 2012 A new analysis concludes that rituximab, a drug ... lasting at least five years in approximately one quarter of ... due to chronic immune thrombocytopenic purpura (ITP). In study ... , the Journal of the American Society of Hematology ...
Cached Medicine Technology:BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012 2Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets 2Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets 3
(Date:5/25/2013)... 2013 On May 25, Voices Against ... and advocacy, comments on a new study by the ... cold atmospheric plasma into brain cancer treatment may help ... a Science Daily article, physicists from the ... physicians demonstrated the “synergistic effect of cold atmospheric plasma ...
(Date:5/25/2013)... May 25, 2013 Dr. Farooq Ashraf, ... clinic in Dubai, has announced his practice’s adoption of ... the only FDA-cleared femtosecond laser proven with more than ... and precision of LASIK. , “We are happy to ... Femtosecond Laser at our Dubai LASIK practice,” Ashraf said ...
(Date:5/25/2013)... May 25, 2013 The Slim Weight Patch ... and results. This is due to the highly sought after ... Slim weight patch offers an extra 2 months supply & ... goals and get the body you desire faster than ever. ... Website , With Slim weight patch consumers can observe ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 For ... than finals week. Increasingly, they are turning to ... awake and study. For more on this, go ... drug treatment facility, warns that students who pick ... are at risk for developing a physical and ...
(Date:5/25/2013)... Richmond, Virginia (PRWEB) May 25, 2013 ... bracelet that relieves pain in seconds for arthritis, tendinitis ... innovator in alternative pain relief products announced a ... seconds. The magnetic bracelet for pain relief is demonstrated ... for pain uses 5400 Gauss magnets and has customers ...
Breaking Medicine News(10 mins):Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2Health News:Atlanta Vision Clinic Acquires the Latest in Blade-Free Lasik Technology Bringing Dubai Patients the Intralase Method 2Health News:Slim Weight Patch Advanced Weight Loss System Offers Extra Two Month Supply and Membership for Maximum Weight Loss 2Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Magnetic bracelet relieves pain in seconds announces Superior Magnetics 2
... , As one of the ... Reform , , WASHINGTON, July ... of civic, business and public policy organizations - including elected representatives ... scope, cost and proposed implementation of President Barack Obama,s endorsed Health ...
... , , , ... DRAD ), today reported that stronger revenue from its Product (nuclear ... $784,000 in net profits and more than $3 million in positive cash ... , , Digirad CEO Todd Clyde said, ...
... SHENYANG, China, July 23 /PRNewswire-Asia-FirstCall/ -- 3SBio ... company focused on,researching, developing, manufacturing and marketing biopharmaceutical,products, today ... quarter ended June 30, 2009 after the US market ... Following the earnings announcement, 3SBio,s senior management will ...
... ... and sleep centers who work with member dentists to recommend and refer those patients who ... appliances to CPAP . , ... (Vocus) July 23, 2009 -- In an effort to encourage more cooperation between sleep physicians ...
... ... Karas among the top Orthopedic Surgeons in the greater Atlanta metro area for the second ... being a ,highly skilled, exceptional, and ,most-trusted, sports medicine specialist. , ... Atlanta, GA (PRWEB) July 23, 2009 -- Spero ...
... SHANGHAI, July 23 /PRNewswire-Asia/ - ... leading pharmaceutical, biotechnology, and medical device,research and development outsourcing ... announced that Dr. Chi-Chung Chan has been appointed as,Vice ... Shuhui Chen,Chief Scientific Officer. , ...
Cached Medicine News:Health News:President Obama's Health Care Plan: Too Big, Too Expensive, Too Rushed 2Health News:President Obama's Health Care Plan: Too Big, Too Expensive, Too Rushed 3Health News:Digirad Corporation Reports Second Quarter 2009 Financial Results 2Health News:Digirad Corporation Reports Second Quarter 2009 Financial Results 3Health News:Digirad Corporation Reports Second Quarter 2009 Financial Results 4Health News:Digirad Corporation Reports Second Quarter 2009 Financial Results 5Health News:Digirad Corporation Reports Second Quarter 2009 Financial Results 6Health News:Digirad Corporation Reports Second Quarter 2009 Financial Results 7Health News:3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009 2Health News:3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009 3Health News:Snoring Isn't Sexy, LLC Announces Commendation Program to Honor Sleep Physicians Who Work with Dentists to Manage Sleep Breathing Disorders 2Health News:Snoring Isn't Sexy, LLC Announces Commendation Program to Honor Sleep Physicians Who Work with Dentists to Manage Sleep Breathing Disorders 3Health News:Atlanta Sports Medicine Doctor Spero Karas Wins 'Atlanta's Top Doctors' Honor Again 2Health News:Atlanta Sports Medicine Doctor Spero Karas Wins 'Atlanta's Top Doctors' Honor Again 3Health News:WuXi PharmaTech Appoints Dr. Chi-Chung Chan as Vice President of Pharmacology 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: